Starpharma Holdings Limited (SPL.AX)
AUD 0.1
(3.09%)
AUD 0.1
(3.09%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.97 Million | -13.53 Million | -13.16 Million | -14.8 Million | -10.77 Million | -10.34 Million |
| Net Income | -8.16 Million | -15.63 Million | -16.15 Million | -19.73 Million | -14.67 Million | -14.25 Million |
| Depreciation & Amortization | 1.11 Million | 1.19 Million | 1.07 Million | 935 Thousand | 911 Thousand | 298 Thousand |
| Deferred income taxes | - | -5.73 Million | -4.59 Million | -6.26 Million | -5.93 Million | -2.95 Million |
| Stock-based compensation | 1.46 Million | 2.06 Million | 2.24 Million | 3.73 Million | 3.6 Million | 3.37 Million |
| Change in working capital | -1.4 Million | -1.04 Million | -140 Thousand | -551 Thousand | -325 Thousand | -422 Thousand |
| Other non-cash items | 4.92 Million | 5.63 Million | 4.39 Million | 7.07 Million | 5.64 Million | 3.61 Million |
| Investing Cash Flow | -89 Thousand | -610 Thousand | -836 Thousand | -246 Thousand | -125 Thousand | -306 Thousand |
| Investments in PPE | -89 Thousand | -621 Thousand | -837 Thousand | -246 Thousand | -125 Thousand | -314 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 11 Thousand | 1000.00 | - | - | 8000.00 |
| Other Investing Activities | - | 11 Thousand | 1000.00 | - | - | 8000.00 |
| Financing Cash Flow | -4.74 Million | -695 Thousand | 3.22 Million | 46.3 Million | -584 Thousand | -26 Thousand |
| Debt repayment | -4 Million | -695 Thousand | -4 Million | -628 Thousand | -584 Thousand | -26 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -1.93 Million | - | - |
| Common Stock Issuance | - | - | - | 48.86 Million | - | - |
| Other Financing Activities | -745 Thousand | -695 Thousand | 7.22 Million | 46.3 Million | -584 Thousand | -26 Thousand |
| Accounts receivables | 2.06 Million | -1.25 Million | 629 Thousand | -2.36 Million | 31 Thousand | -23 Thousand |
| Accounts payables | -3.65 Million | -84 Thousand | 289 Thousand | 2.93 Million | -445 Thousand | 1.14 Million |
| Inventory | 365 Thousand | 51 Thousand | -1.1 Million | -1.22 Million | -95 Thousand | -399 Thousand |
| Other working capital | -175 Thousand | 248 Thousand | 45 Thousand | 111 Thousand | 184 Thousand | -1.14 Million |
| Cash at beginning of period | 35.18 Million | 49.91 Million | 60.5 Million | 30.05 Million | 41.25 Million | 51.31 Million |
| Cash at end of period | 23.36 Million | 35.18 Million | 49.91 Million | 60.5 Million | 30.05 Million | 41.25 Million |
| Capital Expenditure | -89 Thousand | -621 Thousand | -837 Thousand | -246 Thousand | -125 Thousand | -314 Thousand |
| Effect of forex changes on cash | -7000.00 | 100 Thousand | 188 Thousand | -803 Thousand | 288 Thousand | 608 Thousand |
| Net cash flow / Change in cash | -11.82 Million | -14.73 Million | -10.58 Million | 30.44 Million | -11.19 Million | -10.06 Million |
| Free Cash Flow | -7.06 Million | -14.15 Million | -13.99 Million | -15.05 Million | -10.9 Million | -10.65 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -8.16 Million | -7.13 Million | -1.03 Million | -15.63 Million | -7.36 Million | -8.27 Million |
| Depreciation & Amortization | 1.11 Million | 546 Thousand | 569 Thousand | 1.19 Million | 580 Thousand | 613 Thousand |
| Deferred income taxes | - | - | - | -5.73 Million | -2.01 Million | - |
| Stock-based compensation | - | 1.46 Million | - | 2.06 Million | 2.06 Million | - |
| Change in working capital | -1.4 Million | 2.23 Million | - | -1.04 Million | -495 Thousand | - |
| Other non-cash items | 4.92 Million | -6.18 Million | 3.7 Million | 5.63 Million | -513 Thousand | 3.81 Million |
| Investing Cash Flow | -89 Thousand | -80 Thousand | -9000.00 | -610 Thousand | -147 Thousand | -463 Thousand |
| Investments in PPE | -89 Thousand | -80 Thousand | -9000.00 | -621 Thousand | -157 Thousand | -464 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | 11 Thousand | 10 Thousand | 1000.00 |
| Other Investing Activities | - | - | - | 11 Thousand | 10 Thousand | 1000.00 |
| Financing Cash Flow | -4.74 Million | 396 Thousand | -5.14 Million | -695 Thousand | -355 Thousand | -340 Thousand |
| Debt repayment | -4 Million | -776 Thousand | -4.77 Million | -695 Thousand | - | -340 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 396 Thousand | -365 Thousand | -695 Thousand | -355 Thousand | - |
| Accounts receivables | 2.06 Million | 2.06 Million | - | -1.25 Million | -1.25 Million | - |
| Accounts payables | -3.65 Million | - | - | -84 Thousand | - | - |
| Inventory | 365 Thousand | 365 Thousand | - | 51 Thousand | 51 Thousand | - |
| Other working capital | -175 Thousand | -200 Thousand | - | 248 Thousand | 711 Thousand | - |
| Cash at beginning of period | 35.18 Million | 32.13 Million | 35.18 Million | 49.91 Million | 44.03 Million | 49.91 Million |
| Cash at end of period | 23.36 Million | 23.36 Million | 32.13 Million | 35.18 Million | 35.18 Million | 44.03 Million |
| Capital Expenditure | -89 Thousand | -80 Thousand | -9000.00 | -621 Thousand | -157 Thousand | -464 Thousand |
| Effect of forex changes on cash | - | -12 Thousand | 5000.00 | 100 Thousand | 98 Thousand | 2000.00 |
| Net cash flow / Change in cash | -11.82 Million | -8.77 Million | -3.04 Million | -14.73 Million | -8.85 Million | -5.88 Million |
| Free Cash Flow | -7.06 Million | -9.15 Million | 2.08 Million | -14.15 Million | -8.61 Million | -5.54 Million |
STT
1TT
PET
GLOP-PA
SAVE
DIB